![](https://unclineberger.org/wp-content/uploads/sites/867/2019/05/Serody-herophoto-600x400.png)
May 20, 2019
UNC Lineberger designs, develops and delivers CAR-T therapy to attack cancers
Jonathan Serody, MD, explains in a two-minute video the action behind chimeric antigen T-cell, or CAR-T, immunotherapy and how UNC Lineberger is designing, developing and delivering CAR-T therapies to treat cancers that fail to respond to standard treatments.